Browse Title Index


 
Issue Title
 
Vol 11, No 4 (2015): July/August 12-Month safety and effectiveness of once-daily hydrocodone Abstract
Warren Wen, PhD, Louise Taber, MD, Shau Yu Lynch, PhD, Ellie He, PhD, Steven Ripa, MD
 
Vol 10, No 4 (2014): July/August 2014 INTERNATIONAL CONFERENCE ON OPIOIDS Posters presented June 8-10, 2014 Abstract
JOM Editors
 
Vol 12, No 6 (2016): November/December 2017 International Conference on Opioids Announcement Abstract
2017 ICOO Conference Committee
 
Vol 13, No 1 (2017): January/February 2017 International Conference on Opioids Brochure and Schedule Details
Conference Committee
 
Vol 15, No 5 (2019): September/October 2019 International Conference on Opioids Photos Abstract
International Conference on Opioids
 
Vol 15, No 5 (2019): September/October 2019 International Conference on Opioids Posters Abstract
International Conference on Opioids
 
Vol 12, No 6 (2016): November/December A 12-week extension study to assess the safety and tolerability of naloxegol in patients with noncancer pain and opioid-induced constipation Abstract
Lynn Webster, MD, Raj Tummala, MD, MBA, MS, Ulysses Diva, PhD, Jaakko Lappalainen, MD, PhD
 
Vol 14, No 3 (2018): May/June A case for opioid education and training for medical students, residents, and allied health staff: response to “educational intervention for physicians to address the risk of opioid abuse” Abstract
Anees Bahji, BScH, MD, Daenis Camiré, BScN, RN, MD
 
Vol 15, No 3 (2019): May/June A case report of sweating caused by hydromorphone Abstract
Lauren E. Bode, PharmD, BCPS
 
Vol 10, No 3 (2014): May/June A chart review based comparative study of retention rates for two dispensing regimens for buprenorphine for subjects with opioid dependence at a tertiary care substance use disorder treatment center Abstract
Yatan Pal Singh Balhara, MD, DNB, MNAMS
 
Vol 14, No 6 (2018): November/December A claims analysis of the utilization of tramadol for acute pain in patients prescribed buprenorphine/naloxone for opioid use disorder Abstract
Kellye Donovan, PharmD, PhD, MHA, Stephen Kogut, PhD, MBA, Ashley Buchanan, DrPH, MS, Xuerong Wen, PhD, MPH, Robert Crausman, MD, MMS
 
Vol 8, No 2 (2012): March/April A comparative study on the effects of intrathecal morphine added to levobupivacaine for spinal anesthesia Abstract
Hakki Unlugenc, MD, Murat Gunduz, MD, Baris Guzel, MD, Geylan Isik, MD
 
Vol 7, No 5 (2011): September/October A comparison of methods of administering the Opioid Risk Tool Abstract
Ted Jones, PhD, Steven D. Passik, PhD
 
Vol 1, No 5 (2005): November/December A comparison of oral and implant naltrexone outcomes at 12 months Abstract   PDF
Ross Colquhoun, BPsych(Hons), Donald Y-K. Tan, MBBS, Samantha Hull, BPsych(Hons)
 
Vol 3, No 2 (2007): March/April A comparison of oral midazolam, oral tramadol, and intranasal sufentanil premedication in pediatric patients Abstract   PDF
Fatma Bayrak, MD, Isil Gunday, MD, Dilek Memis, MD, Alparslan Turan, MD
 
Vol 2, No 2 (2006): March/April A comparison of patient-controlled epidural pethidine vs. nurse-administered epidural pethidine for analgesia after caesarean section Abstract   PDF
Yvonne Lim, MMed, Sally Wilson, Steven Katz, MD
 
Vol 1, No 1 (2005): March/April A comparison of rapid (opioid) detoxification with clonidine-assisted detoxification for heroin-dependent persons Abstract   PDF
Diane E. Arnold-Reed, PhD, Gary K. Hulse, PhD
 
Vol 13, No 2 (2017): March/April A comprehensive clinical review of opioid-induced allodynia: Discussion of the current evidence and clinical implications Abstract
Corey J. Hayes, PharmD, MPH, Jacob T. Painter, PharmD, MBA, PhD
 
Vol 2, No 2 (2006): March/April A descriptive case series: Oral transmucosal fentanyl use in patients with noncancerous pain Abstract   PDF
Anthony H. Guarino, MD, Jennifer Myers, RN, MSN, ANP, Martha E. Cornell, RN, BSN
 
Vol 15, No 5 (2019): September/October A double blind randomized clinical trial of buprenorphine augmentation for treatment of psychotic symptoms in opioid addicted bipolar patients Abstract
Navid Khalili, MD, Abdolreza Sabahi, MD, Mostafa Vahedian, PhD, Mehdi Alimardanzadeh, MD
 
Vol 7, No 1 (2011): January/February A double-blind, double-dummy, randomized controlled study of memantine versus buprenorphine in naloxone-precipitated acute withdrawal in heroin addicts Abstract
Kushal Jain, MD, Raka Jain, PhD, FRSC Chem, Anju Dhawan, MD
 
Vol 6, No 5 (2010): September/October A double-blind, placebo-controlled study of dual-opioid treatment with the combination of morphine plus oxycodone in patients with acute postoperative pain Abstract
Lynn Webster, MD, Patricia Richards, MD, PhD, Warren Stern, PhD, Robin Kelen, RN, BA, CNN
 
Vol 15, No 3 (2019): May/June A longitudinal analysis of temporal and spatial incidence of neonatal abstinence syndrome in Ontario: 2003-2016 Abstract
Emily Dawson, MPH, Julia Lew, MD Candidate, Dane Mauer-Vakil, BKin, Adam Van Dijk, MSc, Paul Belanger, PhD, Kieran M. Moore, MD
 
Vol 12, No 6 (2016): November/December A more balanced approach to opioid use and management is also needed in end-of-life care Abstract
Sydney Morss Dy, MD, MSc, Cynda Hylton Rushton, PhD, RN, FAAN
 
Vol 10, No 6 (2014): November/December A multicenter, 12-month, open-label, single-arm safety study of oxycodone-hydrochloride/naltrexone-hydrochloride extended-release capsules (ALO-02) in patients with moderate-to-severe chronic noncancer pain Abstract
Samir Arora, MD, Beatrice Setnik, PhD, Michael Drass, MD, John D. Hudson, MD, Ray Clemmer, MS, Paul Meisner, PharmD, Glenn C. Pixton, MS, Veeraindar Goli, MD, Kenneth W. Sommerville, MD
 
Vol 10, No 5 (2014): September/October A multifactorial intervention for hospital opioid management Abstract
Mehmet Akce, MD, Anupam Suneja, MD, Cheryl Genord, RPh, Bonita Singal, MD, PhD, John A. Hopper, MD
 
Vol 14, No 6 (2018): November/December A nasal abuse potential randomized clinical trial of REMOXY® ER, a high-viscosity extended-release oxycodone formulation Abstract
Nadav Friedmann, PhD, MD, Michael R. Marsman, PharmD, Annelies W. de Kater, PhD, Lindsay H. Burns, PhD, Lynn R. Webster, MD
 
Vol 3, No 4 (2007): July/August A new type of harm reduction: Creating an arteriovenous fistula for a compulsively injecting opiate user Abstract
Colin Brewer, MB, Mohammed Sobeh, FRCS
 
Vol 4, No 5 (2008): September/October A PARADOXICAL, NOVEL APPROACH: COMBINING MINUTE NALOXONE WITH MORPHINE INTRATHECAL INFUSION Abstract
Xiulu Ruan, MD
 
Vol 2, No 6 (2006): November/December A patient-activated iontophoretic transdermal system for acute pain management with fentanyl hydrochloride: Overview and applications Abstract   PDF
Kevin T. Bain, PharmD, BCPS, CGP, FASCP
 
Vol 11, No 5 (2015): September/October A pharmacokinetic evaluation of single and multiple doses of extended-release hydrocodone bitartrate in subjects experiencing surgical or osteoarthritic pain Abstract
Cynthia Y. Robinson, PhD, Christopher M. Rubino, PharmD, Stephen J. Farr, PhD
 
Vol 12, No 1 (2016): January/February A phase I study of d-methadone in patients with chronic pain Abstract
Natalie Moryl, MD, Cristina Tamasdan, MD, Dana Tarcatu, MD, Howard T. Thaler, PhD, Denise Correa, PhD, Richard Steingart, MD, FACC, Richard Payne, MD, Eugenie Obbens, MD, PhD
 
Vol 2, No 3 (2006): May/June A Phase II, multicenter, randomized, double-blind, placebo-controlled crossover study of CJC-1008—a long-acting, parenteral opioid analgesic—in the treatment of postherpetic neuralgia Abstract   PDF
Mark S. Wallace, MD, Dwight Moulin, MD, A. J. M. Clark, FRCPC, Ronald Wasserman, MD, Ann Neale, Patricia Morley-Forster, MD, Jean-Paul Castaigne, MD, Sam Teichman, MD
 
Vol 1, No 2 (2005): May/June A Physician’s Guide to Pain and Symptom Management in Cancer Patients. Abstract   PDF
Allen W. Burton, MD
 
Vol 5, No 6 (2009): November/December A pilot study about the feasibility and cost-effectiveness of electronic compliance monitoring in substitution treatment with buprenorphine—naloxone combination Abstract
Ulrich Tacke, MD, PhD, Hanna Uosukainen, MSci (Pharm), Marjo Kananen, BSci (Pharm), Kirsi Kontra, Pharm Lic, Hannu Pentikäinen, MD
 
Vol 10, No 1 (2014): January/February A pilot study of nasal fentanyl for patient controlled treatment of cancer pain Abstract
M. Thronæs, MD, S. Kaasa, MD, PhD, O. Dale, MD, PhD
 
Vol 4, No 2 (2008): March/April A pilot survey of attitudes and knowledge about opioid substitution therapy for HIV-infected prisoners Abstract
Sandra A. Springer, MD, Robert D. Bruce, MD
 
Vol 9, No 5 (2013): September/October A pooled analysis of patient-specific factors and efficacy and tolerability of tapentadol extended release treatment for moderate to severe chronic pain Abstract
Mila Etropolski, MD, Bernd Lange, MD, MSc, Jutta Goldberg, PhD, Achim Steup, Dipl.-Stat., Christine Rauschkolb, MD, PhD
 
Vol 11, No 1 (2015): January/February A primer on definitive gas and liquid chromatography drug testing: What clinicians need to know Abstract
Amadeo Pesce, PhD, Kenneth L. Kirsh, PhD, Angela Huskey, PharmD, CPE, Steven D. Passik, PhD, Catherine A. Hammett-Stabler, PhD
 
Vol 13, No 5 (2017): September/October A public health outbreak management framework applied to surges in opioid overdoses Abstract
Kieran Moore, MD, CCFP (EM), FCFP, MPH, DTM&H, FRCPC, Maximilien Boulet, BSc, Julia Lew, BSc, Nicholas Papadomanolakis-Pakis, BSocSc, MPA
 
Vol 13, No 1 (2017): January/February A qualitative exploration of chronic pain and opioid treatment among HIV patients with drug use disorders Abstract
Sarina R. Isenberg, MA, Allysha C. Maragh-Bass, MPH, PhD, Kathleen Ridgeway, MSPH, Mary Catherine Beach, MD, MPH, Amy R. Knowlton, MPH, ScD
 
Vol 14, No 3 (2018): May/June A qualitative study to develop materials educating patients about opioid use before and after total hip or total knee arthroplasty Abstract
David H. Smith, PhD, RPh, Jennifer Kuntz, PhD, Lynn DeBar, PhD, Jill Mesa, Xiuhai Yang, MS, David Boardman, MD, Jennifer Schneider, MPH
 
Vol 3, No 1 (2007): January/February A randomized, open-label, multicenter trial comparing once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for the treatment of chronic, moderate to severe low back pain: Improved physical functioning in the ACTION trial Abstract   PDF
Richard L. Rauck, MD, Stephen A. Bookbinder, MD, Timothy R. Bunker, MD, Christopher D. Alftine, MD, Steven Gershon, MD, Egbert de Jong, MD, Andres Negro-Vilar, MD, PhD, Richard Ghalie, MD
 
Vol 2, No 6 (2006): November/December A randomized, open-label study of once-a-day AVINZA® (morphine sulfate extended-release capsules) versus twice-a-day OxyContin® (oxycodone hydrochloride controlled-release tablets) for chronic low back pain: The extension phase of the ACTION trial Abstract   PDF
Richard L. Rauck, MD, Stephen A. Bookbinder, MD, Timothy R. Bunker, MD, Christopher D. Alftine, MD, Richard Ghalie, MD, Andres Negro-Vilar, MD, PhD, Egbert de Jong, MD, Steven Gershon, MD
 
Vol 6, No 3 (2010): May/June A randomized, placebo-controlled, double-blinded, parallel-group, 5-week study of buprenorphine transdermal system in adults with osteoarthritis Abstract
Catherine Munera, PhD, Margaret Drehobl, MD, Nelson E. Sessler, PharmD, Craig Landau, MD
 
Vol 1, No 1 (2005): March/April A randomized trial of one-day vs. three-day buprénorphine inpatient detoxification protocols for heroin dependence Abstract   PDF
John A. Hopper, MD, Joanna Wu, BS, Wesley Martus, BS, James D. Pierre, MD
 
Vol 14, No 1 (2018): January/February A Rasch analysis of the Current Opioid Misuse Measure for patients with chronic pain Abstract
Courtney Morris, PhD, Kathy E. Green, PhD, Lilian L. Chimuma, MAT
 
Vol 8, No 2 (2012): March/April A remifentanil/ketamine sedation in surgical cancer patients having severe Parkinson’s disease: Two case reports Abstract
German Salazar, MD, Cyrus Motamed, MD
 
Vol 6, No 6 (2010): November/December A retrospective chart review of opioid-induced nausea and somnolence on commencement for cancer pain treatment Abstract
Yoshiaki Okamoto, BP, Satoru Tsuneto, MD, PhD, Mamiko Tsugane, PhD, Tatsuya Takagi, PhD, Etsuko Uejima, PhD
 
Vol 8, No 3 (2012): May/June A review of epidural and intrathecal opioids used in the management of postoperative pain Abstract
Borja Mugabure Bujedo, MD, Silvia González Santos, MD, Amaia Uría Azpiazu, MD
 
Vol 10, No 3 (2014): May/June A review of rapid-onset opioids for breakthrough pain in patients with cancer Abstract
Steven M. Simon, RPh, MD, Lee S. Schwartzberg, MD, FACP
 
Vol 9, No 5 (2013): September/October A review of the use of ketamine in pain management Abstract
Qutaiba A. Tawfic, MBChB, FIBMS (Anesthesiology)
 
Vol 14, No 1 (2018): January/February A snap shot of patients’ recall, attitudes, and perceptions of their pain contracts from a family medicine resident outpatient clinic Abstract
Robinder Bahniwal, MD, Jarrett Sell, MD, Abdul Waheed, MD, FAAFP
 
Vol 2, No 2 (2006): March/April A summary of current Drug Enforcement Administration positions and resulting federal legal and regulatory “standards” Abstract   PDF
Jennifer Bolen, JD
 
Vol 7, No 1 (2011): January/February A systematic compilation of reports published on opioid-related problems Abstract
Matthew Butts, MD, Aminah Jatoi, MD
 
Vol 10, No 1 (2014): January/February A systematic review of smartphone applications for chronic pain available for download in the United States Abstract
Lorraine S. Wallace, PhD, Lara K. Dhingra, PhD
 
Vol 9, No 5 (2013): September/October Aberrant behaviors in a primary care-based cohort of patients with chronic pain identified as misusing prescription opioids Abstract
Martin D. Cheatle, PhD, Charles P. O’Brien, MD, PhD, Koshy Mathai, MD, Matthew Hansen, MD, Mario Grasso, MD, Peter Yi, MD
 
Vol 12, No 3 (2016): May/June Abuse deterrence testing: A dose ratio escalation study examining naloxone coadministered with intravenous hydromorphone in non-treatment-seeking, opioid-dependent drug users Abstract
Naama Levy-Cooperman, PhD, Kerri A. Schoedel, PhD, Joseph L. Reiz, BSc, David Thompson, PhD, Bijan Chakaraborty, MStat, Pierre Geoffroy, MD, Kenneth J. Michalko, PharmD, MBA
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Abuse Deterrent Opioids: Clinical and Public Policy Implications Abstract
Richard A. DeVito, Jr
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Abuse of reformulated OxyContin: Updated findings from a sentinel surveillance sample of individuals assessed for substance use disorder Abstract
Theresa A. Cassidy, MPH, Eileen Thorley, MPH, Ryan A. Black, PhD, Angela DeVeaugh-Geiss, PhD, Stephen F. Butler, PhD, Paul Coplan, ScD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Abuse-deterrent features of an extended-release morphine drug product developed using a novel injection-molding technology for oral drug delivery Abstract
Nikolaj Skak, MS, Torben Elhauge, MSc, Jeffrey M. Dayno, MD, Karsten Lindhardt, MSc, PhD, DBE
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Abuse-deterrent formulations approval reform: Will clinical correctness or real-world results be used to address the nation's opioid crisis: “Noninterference” as a new approval standard Abstract
Dan Cohen, MA/LS
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Abuse-deterrent formulations of opioids: Many questions still to answer Abstract
Raeford E. Brown Jr, MD, FAAP
 
Vol 14, No 6 (2018): November/December Abuse-deterrent properties of REMOXY® ER, a high-viscosity extended-release oxycodone formulation Abstract
Shawn A. Kucera, PhD, Michael S. Zamloot, BS ChE, Michael M. Crowley, PhD, Lindsay H. Burns, PhD, Nadav Friedmann, PhD, MD, Remi Barbier, MBA
 
Vol 10, No 4 (2014): July/August Academic family medicine physicians' confidence and comfort with opioid analgesic prescribing for patients with chronic nonmalignant pain Abstract
Allison A. Macerollo, MD, Donald O. Mack, MD, Rupal Oza, MD, MPH, Ian M. Bennett, MD, PhD, Lorraine S. Wallace, PhD
 
Vol 12, No 3 (2016): May/June Acceptability of the use of cellular telephone and computer pictures/video for “pill counts” in buprenorphine maintenance treatment Abstract
Christopher Welsh, MD
 
Vol 12, No 1 (2016): January/February Acetaminophen, a reasonable option, but not a panacea Abstract
Xiulu Ruan, MD, Praveen Narahari, MD, MS, Alan D. Kaye, MD, PhD
 
Vol 10, No 6 (2014): November/December Activity-based cost analysis of opioid-related nausea and vomiting among inpatients Abstract
Leopold Eberhart, MD, Tilo Koch, MSc, Peter Kranke, MD, Dirk Rüsch, MD, Alexander Torossian, MD, Stefan Nardi-Hiebl, MBA
 
Vol 6, No 4 (2010): July/August Acute opioid withdrawal precipitated by ingestion of crushed Embeda (morphine extended release with sequestered naltrexone): Case report and the focused review of the literature Abstract
Xiulu Ruan, MD, Tao Chen, MD, PhD, Jeff Gudin, MD, John Patrick Couch, MD, Srinivas Chiravuri, MD
 
Vol 5, No 4 (2009): July/August ADDICTION VERSUS DEPENDENCE: CARRYING THE DEBATE FORWARD Abstract
Yatan Pal Singh Balhara, MD, DNB, Shachi Mathur, MA, CHt, PhD Scholar
 
Vol 15, No 3 (2019): May/June Addressing the opioid crisis: An assessment of clinicians’ training experience, practices, and attitudes within a large healthcare organization Abstract
Harshal Kirane, MD, Elina Drits, DO, Seungjun Ahn, MS, Sandeep Kapoor, MD, Jonathan Morgenstern, PhD, Joseph Conigliaro, MD, Jay Enden, MD
 
Vol 12, No 5 (2016): September/October Adherence to chronic opioid therapy prescribing guidelines in a primary care clinic Abstract
Cynthia Kay, MD, MS, Erica Wozniak, MS, Sarah Koller, DO, Audrey Ye, MD, Joanne Bernstein, MD
 
Vol 8, No 4 (2012): July/August Advantages of EMBEDA® (morphine sulfate and naltrexone hydrochloride) extended-release capsules in pain management Abstract
Shailendra Kapoor, MD
 
Vol 2, No 3 (2006): May/June Adverse effects and cognitive function among primary care patients taking opioids for chronic nonmalignant pain Abstract   PDF
Randall T. Brown, MD, Megan Zuelsdorff, BS, Michael Fleming, MD, MPH
 
Vol 8, No 3 (2012): May/June Affect of genetic polymorphisms on pain perception and pain management in lung cancer survivors Abstract
Shailendra Kapoor, MD
 
Vol 15, No 1 (2019): January/February Age differences in the association of nonmedical prescription opioid use and suicidality Abstract
Keith T. Chan, MSW, PhD, Priya Winston, MSW, Rubin Jennings, MS, Jeffrey Trant, MSW, Mary Moller, MSW
 
Vol 9, No 2 (2013): March/April Age, gender, and earlier opioid requirement associations with the rate of dose escalation in long-term opioid therapy Abstract
Huijun Han, MD, PhD, Philip H. Kass, DVM, PhD, Barth L. Wilsey, MD, Chin-Shang Li, PhD
 
Vol 15, No 4 (2019): July/August An Acute Pain Service experience initiating methadone for opioid use disorder in hospitalized patients with acute pain Abstract
Rebecca C. Dale, DO, Carol L. Metcalf, MN, ARNP, Dale J. Langford, Christina E. Bockman, PharmD, Debra B. Gordon, DNP, RN, FAAN, Daniel L. Krashin, MD, Katherin A. Peperzak, MD, Andrea K. Breuner, PA-C, Michelle C. Accardi-Ravid, PhD, Ivan K. Lesnik, MD
 
Vol 13, No 1 (2017): January/February An analysis of errors, discrepancies, and variation in opioid prescriptions for adult outpatients at a teaching hospital Abstract
Mark C. Bicket, MD, Deepa Kattail, MD, Myron Yaster, MD, Christopher L. Wu, MD, Peter Pronovost, MD, PhD
 
Vol 10, No 3 (2014): May/June An evaluation of the performance of the Opioid Manager clinical tool in primary care: A qualitative study Abstract
Andrew Robertson, BSc, MD (Candidate), Sander L. Hitzig, PhD, Andrea D. Furlan, MD, PhD
 
Vol 3, No 5 (2007): September/October An evaluation of the predictive validity of the Pain Medication Questionnaire with a heterogeneous group of patients with chronic pain Abstract
Leah S. Dowling, MS, Robert J. Gatchel, PhD, Laura L. Adams, PhD, Anna W. Stowell, PhD, Dana Bernstein, MS, PhD
 
Vol 7, No 1 (2011): January/February An improved method of determining ethanol use in a chronic pain population Abstract
Bridgit Crews, PhD, Robert West, MS, Ronita Gutierrez, CLS, Sergey Latyshev, MS, Charles Mikel, PhD, Perla Almazan, CLS, MT (ASCP), Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Murray Rosenthal, DO, FAPA
 
Vol 8, No 6 (2012): November/December An open-label pharmacokinetic study of oxymorphone extended release in the presence of naltrexone in the older adult Abstract
Joseph V. Pergolizzi Jr, MD, Robert B. Raffa, PhD, Robert Taylor Jr, PhD, Swati Nagar, PhD, Sumedha Labhsetwar, MD, Nicholas Sinclair, MD, Errol M. Gould, PhD
 
Vol 7, No 3 (2011): May/June Analgesic and adverse effects of a fixed-ratio morphine-oxycodone combination (MoxDuo®) in the treatment of postoperative pain Abstract
Patricia Richards, MD, PhD, Dennis Riff, MD, Robin Kelen, RN, Warren Stern, PhD
 
Vol 3, No 3 (2007): May/June Analgesic effects of lornoxicam after total abdominal hysterectomy Abstract   PDF
Ozgur Sapolya, MD, Beyhan Karamanlhoglu, MD, Dilek Memis, MD
 
Vol 7, No 4 (2011): July/August Analgesic efficacy of intravenous naloxone for the treatment of postoperative pruritus: A meta-analysis Abstract
Jamie D. Murphy, MD, Harold J. Gelfand, MD, Mark C. Bicket, MD, Jean-Pierre P. Ouanes, DO, Kanupriya K. Kumar, MD, Gillian R. Isaac, MD, PhD, Christopher L. Wu, MD
 
Vol 7, No 4 (2011): July/August Analgesic treatment for moderate-to-severe acute pain in the United States: Patients’ perspectives in the Physicians Partnering Against Pain (P3) Survey Abstract
Bruce L. Moskovitz, MD, Carmela J. Benson, MS, Aarti A. Patel, MBA, PharmD, Wing Chow, MPH, PharmD, Samir H. Mody, MBA, PharmD, Bill H. McCarberg, MD, Myoung S. Kim, MBA, MA, PhD
 
Vol 12, No 2 (2016): March/April Analgesic utilization before and after rescheduling of hydrocodone in a large academic level 1 trauma center Abstract
Steven Schultz, PharmD, Carol Chamberlain, PharmD, Psych MA, Marius Vulcan, MD, Humair Rana, MD, Bhavin Patel, PharmD, MBA, John C. Alexander, MD
 
Vol 7, No 3 (2011): May/June Analysis of the paramedic administration of fentanyl Abstract
Jocelyn Freeman Garrick, MD, FACEP, Senai Kidane, MD, EMS Fellow, James E. Pointer, MD, William Sugiyama, MA, RN, NREMT-P, Christopher Van Luen, EMT-P, Rebecca Clark, EMT-B
 
Vol 12, No 1 (2016): January/February Analyzing the relationship between nonmedical prescription-opioid use and heroin use Abstract
Xiulu Ruan, MD, Melville Q. Wyche, III, MD, Alan David Kaye, MD, PhD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Application of hot-melt extrusion technology in immediate-release abuse-deterrent formulations Abstract
Klaus Wening, PhD, Sebastian Schwier, PhD, Hans-J. Stahlberg, MD, Eric Galia, PhD
 
Vol 6, No 4 (2010): July/August Applying partially occluded fentanyl transdermal patches to manage pain in pediatric patients Abstract
Amy Mitchell, PharmD, Howard S. Smith, MD
 
Vol 14, No 4 (2018): July/August Are physicians fully aware of the potential transgenerational and multigenerational effects of a large opioid misuse in the population? Abstract
Maurizio Coppola, MD, Raffaella Mondola, MD
 
Vol 3, No 3 (2007): May/June Are we still scratching the surface? A case of intractable pruritus following systemic opioid analgesia Abstract   PDF
Dana Tarcatu, MD, Cristina Tamasdan, MD, Natalie Moryl, MD, Eugenie Obbens, MD, PhD
 
Vol 3, No 6 (2007): November/December Arrested on heroin: A national opportunity Abstract
Amy E. Boutwell, MD, MPP, Ank Nijhawan, MD, Nickolas Zaller, PhD, Josiah D. Rich, MD, MPH
 
Vol 14, No 5 (2018): September/October Assessing risk of opioid misuse in the treatment of chronic pain: Building a practical actuarial approach Abstract
David M. Erekson, PhD, Liliana Bautista, Dallin Albright
 
Vol 8, No 5 (2012): September/October Assessing subjective and physiologic effects following intranasal administration of a new formulation of immediate release oxycodone HCl (Oxecta™) tablets in nondependent recreational opioid users Abstract
Kerri A. Schoedel, PhD, Robert L. Rolleri, PharmD, Janice Y. Faulknor, MD, CCFP, Glenn C. Pixton, MS, Nancy Chen, PhD, Almasa Bass, PharmD, Kenneth W. Sommerville, MD, Edward Sellers, MD, PhD, FRCPC, FACP
 
Vol 13, No 3 (2017): May/June Assessing the impact of the extended-release/long-acting opioid analgesics risk evaluation and mitigation strategies on opioid prescription volume Abstract
Victoria Divino, BA, M. Soledad Cepeda, MD, PhD, Paul Coplan, ScD, MBA, MPH, Jean-Yves Maziere, MD, PhD, Yingli Yuan, PhD, Rolin L. Wade, RPh, MS
 
Vol 12, No 6 (2016): November/December Assessment of abuse liability of Tramadol among experienced drug users: Double-blind crossover randomized controlled trial Abstract
Mrinmay Das, MBBS, MD, Raka Jain, MSc, PhD, CChem FRSC (UK), Anju Dhawan, MBBS, MD, Amandeep Kaur, MBBS, MD
 
Vol 12, No 5 (2016): September/October Assessment of acute pain in trauma—A retrospective prehospital evaluation Abstract
Stine Hebsgaard, MD, Anne Mannering, MD, Stine T. Zwisler, MD, PhD
 
Vol 14, No 2 (2018): March/April Assessment of outcomes following high-dose opioid tapering in a Veterans Healthcare System Abstract
Lauren Hundley, PharmD, BCPS, Shelley Spradley, PharmD, BCPS, Scott Donelenko, BPharm, CPE
 
Vol 8, No 6 (2012): November/December Assessment of the abuse of tapentadol immediate release: The first 24 months Abstract
Richard C. Dart, MD, PhD
 
Vol 11, No 5 (2015): September/October Assessment of the use of oral fluid as a matrix for drug monitoring in patients undergoing treatment for opioid addiction Abstract
Frank Kunkel, MD, Elizabeth Fey, MS, Damon Borg, PhD, Richard Stripp, PhD, Christine Getto, BS
 
Vol 7, No 6 (2011): November/December Assessment, stratification, and monitoring of the risk for prescription opioid misuse and abuse in the primary care setting Abstract
James Brown, MD, Beatrice Setnik, PhD, Keung Lee, MD, PhD, Linda Wase, MD, Carl L. Roland, PharmD, Jody M. Cleveland, MS, Sherry Siegel, MD, Nathaniel Katz, MD, MS
 
Vol 14, No 4 (2018): July/August Association between the North Carolina Medical Board opioid guideline update and opioid prescriptions in Medicare Part D beneficiaries Abstract
Chris Gillette, PhD, Mark A. Bush, PhD, Kate M. L. Rogers, PharmD Candidate, Geoffrey Mospan, PharmD, BCPS, Kimberly Nealy, PharmD, BCPS, CDE, CPP, Michelle DeGeeter, PharmD, BCACP, CDE, April M. Robinson, PharmD, BCPS
 
Vol 4, No 2 (2008): March/April Association of transdermal fentanyl and oral transmucosal fentanyl citrate in the treatment of opioid naïve patients with severe chronic noncancer pain Abstract
Francisco Collado, MD, PhD, Luis M. Torres, MD, PhD
 
Vol 14, No 3 (2018): May/June Associations between pain coping and opioid use: One-month follow-up results of a prospective study in a cohort of traumatic injury patients Abstract
Jordan C. Smith, BS, Christopher R. Nicholas, PhD, Scott J. Hetzel, MS, Bri M. Deyo, MPH, Randall T. Brown, MD, PhD
 
Vol 9, No 1 (2013): January/February Associations between public health indicators and injecting prescription opioids by prescription opioid abusers in substance abuse treatment Abstract
Ryan A. Black, PhD, Kimberlee J. Trudeau, PhD, Theresa A. Cassidy, MPH, Simon H. Budman, PhD, Stephen F. Butler, PhD
 
Vol 15, No 3 (2019): May/June Attitudes and self-reported practices of orthopedic providers regarding prescription opioid use Abstract
Deepa Kattail, MD, MHS, Aaron Hsu, MHS, Myron Yaster, MD, Paul T. Vozzo, BA, Shuna Gao, BA, John M. Thompson, MD, Debra L. Roter, DrPH, Dawn Laporte, MD, R. Frank Henn 3rd, MD, John E. Fiadjoe, MD, Constance L. Monitto, MD
 
Vol 12, No 6 (2016): November/December Attitudes toward the Canadian Guideline for Safe and Effective Use of Opioids for Chronic Non-Cancer Pain: A qualitative study Abstract
Yaping Chang, MSc, Kan Lun Zhu, Ivan D. Florez, MD, MSc, Sung Min Cho, BHSc, Nasim Zamir, HBSc, Augustin Toma, BESc, Reza Donald Mirza, MD, Gordon H. Guyatt, MD, MSc, Norman Buckley, MD, Jason W. Busse, DC, PhD
 
Vol 3, No 5 (2007): September/October Attributes and behaviors associated with opioid seeking in the emergency department Abstract
Lisa Chan, MD, Billie Winegard, MPH
 
Vol 6, No 1 (2010): January/February AWAKE FIBEROPTIC INTUBATION WITH TARGET-CONTROLLED INFUSION OF REMIFENTANIL IN EMERGENCY SURGERY Abstract
Cyrus Motamed, MD, German Salazar, MD
 
Vol 9, No 6 (2013): November/December Awareness of, experience with, and attitudes toward buprenorphine among opioid users visiting a New York City syringe exchange program Abstract
Pooja A. Shah, BS, Nancy L. Sohler, PhD, MPH, Carolina López, BA, Aaron D. Fox, MD, Chinazo O. Cunningham, MD, MS
 
Vol 15, No 4 (2019): July/August “We get tunnel vision”: Emergency medical service providers’ views on the opioid epidemic in Baltimore City Abstract
Allysha C. Maragh-Bass, PhD, MPH, Julie C. Fields, MD, PhD, Zachary Catanzarite, MA, Amy R. Knowlton, ScD, MPH
 
Vol 4, No 5 (2008): September/October Balanced anesthesia with remifentanil and desflurane: Clinical considerations for dose adjustment in adults Abstract
Ralph Nöst, MD, Antje Thiel-Ritter, MD, Stefan Scholz, MD, Gunter Hempelmann, MD, Matthias Müller, MD
 
Vol 11, No 5 (2015): September/October Balancing opioid-induced gastrointestinal side effects with pain management: Insights from the online community Abstract
Cynthia B. Whitman, MPH, Mark W. Reid, PhD, Corey Arnold, PhD, Lyann Ursos, PhD, Roee Sa’adon, MS, Jonathan Pourmorady, MD, Brennan M. R. Spiegel, MD, MSHS, Haridarshan Patel, PharmD
 
Vol 2, No 1 (2006): January/February Barriers and facilitators to methadone maintenance therapy use among illicit opiate injection drug users in Vancouver Abstract   PDF
Cody Callon, BSc, Evan Wood, PhD, David Marsh, MD, Kathy Li, PhD, Julio Montaner, MD, Thomas Kerr, PhD
 
Vol 10, No 6 (2014): November/December Beliefs and attitudes about opioid prescribing and chronic pain management: Survey of primary care providers Abstract
Robert N. Jamison, PhD, Kerry Anne Sheehan, BA, Elizabeth Scanlan, NP, Michele Matthews, PharmD, Edgar L. Ross, MD
 
Vol 7, No 6 (2011): November/December Beliefs and attitudes about prescribing opioids among healthcare providers seeking continuing medical education Abstract
W. Michael Hooten, MD, Barbara K. Bruce, PhD
 
Vol 7, No 2 (2011): March/April Bioequivalence and safety of a novel fentanyl transdermal matrix system compared with a transdermal reservoir system Abstract
Kenneth Todd Moore, MS, Holly D. Adams, MS, Jaya Natarajan, PhD, Jay Ariyawansa, MS, Henry M. Richards, MD
 
Vol 15, No 1 (2019): January/February Biopsychosocial determinants of opioid use disorder (OUD) and implications for maternal and child health research: A scoping review Abstract
Hamisu M. Salihu, MD, PhD, Abraham Salinas, MD, PhD, Imelda Medina, MD, MPH, Janani Krishnaswami, MD, MPH, Muktar H. Aliyu, MD, DrPH
 
Vol 15, No 5 (2019): September/October Birth outcomes with prescribed chronic and acute opioid exposure during pregnancy Abstract
Thomas Delate, PhD, MS, Megan Hodges, PharmD, Morgan Swank, MD, Taylor Ota, PharmD Candidate, Christy L. Pratt, PharmD
 
Vol 15, No 5 (2019): September/October "Blister packs" rather than "ashes to ashes, dust to dust" for medications Abstract
Deepak Gupta, MD, Shushovan Chakrabortty, MD, PhD
 
Vol 6, No 2 (2010): March/April Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 1: Prevalence and characteristics Abstract
Russell K. Portenoy, MD, Daniel Bruns, PsyD, Bonnie Shoemaker, BSN, Steven A. Shoemaker, MD
 
Vol 6, No 2 (2010): March/April Breakthrough pain in community-dwelling patients with cancer pain and noncancer pain, Part 2: Impact on function, mood, and quality of life Abstract
Russell K. Portenoy, MD, Daniel Bruns, PsyD, Bonnie Shoemaker, BSN, Steven A. Shoemaker, MD
 
Vol 2, No 6 (2006): November/December Breakthrough pain in opioid-treated patients with neuropathic pain Abstract   PDF
Steve Simon, MD, RPh, Daniel S. Bennett, MD, Richard Rauck, MD, Donald Taylor, MD, Steven Shoemaker, MD
 
Vol 8, No 1 (2012): January/February Buprenorphine therapy for opioid addiction in rural Washington: The experience of the early adopters Abstract
Tyler L. Quest, BS, Joseph O. Merrill, MD, John Roll, PhD, Andrew J. Saxon, MD, Roger A. Rosenblatt, MD, MPH
 
Vol 5, No 1 (2009): January/February Buprenorphine: A review Abstract
Sidarth Wakhlu, MD
 
Vol 3, No 1 (2007): January/February Buprenorphine: A unique opioid with broad clinical applications Abstract   PDF
Nalini Vadivelu, MD, Roberta L. Hines, MD
 
Vol 3, No 4 (2007): July/August Buprenorphine—A review of its role in neuropathic pain Abstract
Guy Hans, MD
 
Vol 6, No 4 (2010): July/August Burden of opioid-associated gastrointestinal side effects from clinical and economic perspectives: A systematic literature review Abstract
Kim Boswell, MD, Winghan Jacqueline Kwong, PharmD, PhD, Shane Kavanagh, MSc
 
Vol 1, No 1 (2005): March/April Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 2 (2005): May/June Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 3 (2005): July/August Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 4 (2005): September/October Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 1, No 5 (2005): November/December Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 1 (2006): January/February Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 2 (2006): March/April Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 3 (2006): May/June Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 4 (2006): July/August Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 2, No 5 (2006): September/October Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 1 (2007): January/February Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 3, No 2 (2007): March/April Calendar Abstract   PDF
Richard A. DeVito, Jr.
 
Vol 12, No 4 (2016): July/August Call For Papers - Special Abuse Deterrent Formulation Issue Abstract
Lynn Webster, MD
 
Vol 12, No 4 (2016): July/August Call for Proposals for Papers, Posters, Presentations, Symposia and Corporate Satellite Symposia for ICOO2017 Abstract
Paul Sloan, MD
 
Vol 13, No 3 (2017): May/June Can 28-day prescription prevent unintentional medication surplus with 30-day prescription? Abstract
Deepak Gupta, MD, Shushovan Chakrabortty, MD, PhD
 
Vol 5, No 5 (2009): September/October Can the cognitively impaired safely use patient-controlled analgesia? Abstract
Eugene Licht, MD, Eugenia L. Siegler, MD, M. Carrington Reid, MD, PhD
 
Vol 3, No 1 (2007): January/February Can we continue to do business as usual? Abstract   PDF
B. Eliot Cole, MD, MPA
 
Vol 8, No 3 (2012): May/June Cancer pain in the opioid-addicted patient: Can we treat it right? Abstract
Vania Modesto-Lowe, MD, MPH, Lisa Girard, BS, MHS, PA-C, Margaret Chaplin, MD
 
Vol 4, No 6 (2008): November/December Cancer pain management at a tertiary care cancer center in India—A retrospective analysis of 3,238 patients Abstract
Sushma Bhatnagar, MD, Seema Mishra, MD, Madhurima Srikanti, MD, Deepak Gupta, MD
 
Vol 2, No 4 (2006): July/August Capnography monitoring during opioid PCA administration Abstract   PDF
Rob Hutchison, PharmD
 
Vol 10, No 2 (2014): March/April Case study investigating effect of implementing strategies for Reducing patient complaints in an outpatient pain clinic Abstract
Cheryl D. Bernstein, MD, Mohammed Khan, MD, Adeel Haq, MD, Nadia Olszanski, RN, Dawn A. Marcus, MD
 
Vol 8, No 6 (2012): November/December Case Study. Transdermal buprenorphine controls central neuropathic pain Abstract
Michelle Weiner, DO, MPH
 
Vol 12, No 4 (2016): July/August Caveat emptor: Erroneous safety information about opioids in online drug-information compendia Abstract
Sonia R. Talwar, PharmD, Amarita S. Randhawa, PharmD, Erica H. Dankiewicz, PharmD, Nancy T. Crudele, PharmD, J. David Haddox, DDS, MD
 
Vol 6, No 6 (2010): November/December Cerebral measurements and their correlation with the onset age and the duration of opioid abuse Abstract
Reetta Kivisaari, MD, PhD, Pekka Rapeli, Psyc. Lic., Koen Van Leemput, PhD, Seppo Kähkönen, MD, PhD, Varpu Puuskari, MD, Olga Jokela, MD, Taina Autti, MD, PhD
 
Vol 13, No 4 (2017): July/August Characteristics and treatment patterns of US commercially insured and Medicaid patients with opioid dependence or abuse Abstract
Bernd A. Wollschlaeger, MD, FAAFP, FASAM, Tina M. Willson, PhD, Leslie B. Montejano, MA, CCRP, Naoko A. Ronquest, PhD, Vijay R. Nadipelli, BPharm, MS
 
Vol 7, No 5 (2011): September/October Characteristics of a nontreatment-seeking sample of over-the-counter codeine users: Implications for intervention and prevention Abstract
Suzanne Nielsen, BPharm, BPharmSc (Hons), PhD, Jacqui Cameron, BA, BSW, MPhil (Social Science Research), Nicole Lee, BSc (Hons), GradCertEd (Tertiary), PhD, MAPS
 
Vol 5, No 5 (2009): September/October Characteristics of patients with chronic pain accessing treatment with medical cannabis in Washington State Abstract
Sunil K. Aggarwal, PhD, MD Candidate, Gregory T. Carter, MD, MS, Mark D. Sullivan, MD, PhD, Craig ZumBrunnen, PhD, Richard Morrill, PhD, Jonathan D. Mayer, PhD
 
Vol 8, No 5 (2012): September/October Characteristics of prescribers whose patients shop for opioids: Results from a cohort study Abstract
M. Soledad Cepeda, MD, PhD, Daniel Fife, MD, Jesse A. Berlin, ScD, Gregory Mastrogiovanni, BS, Yingli Yuan, PhD
 
Vol 6, No 4 (2010): July/August Characteristics of prescription opioid abusers in treatment: Prescription opioid use history, age, use patterns, and functional severity Abstract
Stephen F. Butler, PhD, Ryan A. Black, PhD, Jill M. Grimes Serrano, PhD, Mollie E. Wood, MPH, Simon H. Budman, PhD
 
Vol 14, No 5 (2018): September/October Characteristics of prior emergency departments visits associated with subsequent opioid overdose Abstract
Elias Youssef, MD, MBA, Han Tony Gao, MD, Conor Russell, MD, Shorok Hassan, MD, Brahim Ardolic, MD, Barry Hahn, MD
 
Vol 9, No 6 (2013): November/December Characterization of opioid overdose and response in a high-risk community corrections sample: A preliminary study Abstract
Karen L. Cropsey, PsyD, Stephen Martin, MD, EdM, C. Brendan Clark, PhD, Cheryl B. McCullumsmith, MD, PhD, Peter S. Lane, DO, Sonya Hardy, MS, Peter S. Hendricks, PhD, Nicole Redmond, MD, PhD, MPH
 
Vol 1, No 5 (2005): November/December Cholecystokinin antagonists: Can they augment opioid-derived analgesia? Abstract   PDF
Gary McCleane, MD
 
Vol 11, No 1 (2015): January/February Choosing the right laboratory: A review of clinical and forensic toxicology services for urine drug testing in pain management Abstract
Gary M. Reisfield, MD, Bruce A. Goldberger, PhD, Roger L. Bertholf, PhD
 
Vol 5, No 5 (2009): September/October Chronic opioid therapy issues associated with opioid abuse potential Abstract
Howard S. Smith, MD, Kenneth L. Kirsh, PhD, Steven D. Passik, PhD
 
Vol 12, No 4 (2016): July/August Clinical analgesia correlates with decline in temporal summation in response to remifentanil infusion in patients with chronic neuropathic (radicular) pain Abstract
Erica Suzan, PhD, Ayelet Midbari, MD, Dorit Pud, PhD, Salim Hadad, PhD, Elon Eisenberg, MD
 
Vol 9, No 6 (2013): November/December Clinical applications of oxymorphone Abstract
Nalini Vadivelu, MD, Monisa Maria, MBBS, Suneil Jolly, MD, Julia Rosenbloom, MD, Arun Prasad, MD, Alan David Kaye, MD, PhD
 
Vol 8, No 4 (2012): July/August Clinical effectiveness and safety of OROS® hydromorphone in breakthrough cancer pain treatment: A multicenter, prospective, open-label study in Korean patients Abstract
Kyung Hee Lee, MD, Min Kyoung Kim, MD, Myung Soo Hyun, MD, Jin Young Kim, MD, Keon Uk Park, MD, Hong Suk Song, MD, PhD, Sun Ah Lee, MD, Won Sik Lee, MD, Sung Hwa Bae, MD, Hun Mo Ryoo, MD, Yoon Young Cho, MD
 
Vol 10, No 6 (2014): November/December Clinical interpretation of opioid tolerance versus opioid-induced hyperalgesia Abstract
Lucy Chen, MD, Michael Sein, MD, Trang Vo, BA, Shihab Amhmed, MD, Yi Zhang, MD, Kristin St Hilaire, BA, PhD, Mary Houghton, BA, Jianren Mao, MD, PhD
 
Vol 4, No 6 (2008): November/December Clinical rationale for administering fentanyl to cancer pain patients: Two Delphi surveys of pain management experts in Denmark Abstract
Ramune Jacobsen, MS, MPH, Claus Møldrup, PhD, Lona Christrup, PhD
 
Vol 13, No 2 (2017): March/April Clinical relevance of the pharmacokinetic characteristics of an abuse-deterrent, extended-release, injection-molded morphine tablet Abstract
Jeffrey M. Dayno, MD, Gwendolyn Niebler, DO, John Lawler, BS, Torben Elhauge, MSc, Karsten Lindhardt, MSc, PhD, DBE
 
Vol 12, No 5 (2016): September/October Clinically relevant concentrations of opioids for in vitro studies Abstract
Jason W. Boland, FRCP, PhD, A. Graham Pockley, PhD
 
Vol 14, No 5 (2018): September/October Clinician opioid prescribing practices and patient utilization of prescribed opioids in pediatrics Abstract
Jeannie S. Huang, MD, MPH, Cynthia L. Kuelbs, MD
 
Vol 11, No 3 (2015): May/June Communication about opioid versus nonopioid analgesics in the emergency department Abstract
Danielle M. McCarthy, MD, MS, Kenzie A. Cameron, PhD, MPH, D. Mark Courtney, MD, MS, James G. Adams, MD, Kirsten G. Engel, MD
 
Vol 14, No 3 (2018): May/June Communication between nurse care managers and patients who take opioids for chronic pain: Strategies for exploring aberrant behavior Abstract
Jane M. Liebschutz, MD, MPH, Allison V. Lange, MD, Orlaith D. Heymann, MA, Karen E. Lasser, MD, MPH, Pamela Corey, MSN, EdD, RN, CHSE, Christopher W. Shanahan, MD, MPH, Hannah S. Kopinski, BA, Jawad M. Husain, MD, Phoebe A. Cushman, MD, MS, Victoria A. Parker, EdM, DBA
 
Vol 13, No 4 (2017): July/August Comparing methods of naloxone administration: A narrative review Abstract
Shawn E. Fellows, PharmD, Alexander J. Coppola, BS, EMT-B, PharmD, Mona A. Gandhi, PharmD
 
Vol 9, No 6 (2013): November/December Comparison of 75 and 150 µg doses of intrathecal morphine for postoperative analgesia after transurethral resection of the prostate under spinal anesthesia Abstract
Halime Özbek, MD, Mustafa N. Deniz, MD, Arzum Erakgun, MD, Elvan Erhan, MD
 
Vol 9, No 1 (2013): January/February Comparison of efficacy between buprenorphine and tramadol in the detoxification of opioid (heroin)-dependent subjects Abstract
Jatinder Mohan Chawla, MD, Hemraj Pal, MD, Rakesh Lal, MD, Raka Jain, PhD, Nina Schooler, PhD, Yatan Pal Singh Balhara, MD
 
Vol 6, No 6 (2010): November/December Comparison of postoperative analgesia with epidural butorphanol/bupivacaine versus fentanyl/bupivacaine following pediatric urological procedures Abstract
Alexandra Szabova, MD, Senthilkumar Sadhasivam, MD, MPH, Yu Wang, MS, Todd G. Nick, PhD, Kenneth Goldschneider, MD
 
Vol 5, No 5 (2009): September/October Comparison of the effect of adding remifentanil to patient-controlled tramadol or morphine for postoperative analgesia after major abdominal surgery Abstract
Hakki Unlugenc, MD, Sibel Tetiker, MD, Selim Büyükkurt, MD, Tayfun Guler, MD, Geylan Isik, MD
 
Vol 6, No 2 (2010): March/April Comparison of the postoperative analgesic efficacy of intravenous patient-controlled analgesia with tramadol to intravenous patient-controlled analgesia with opioids Abstract
Jamie D. Murphy, MD, Dawn Yan, MD, Marie N. Hanna, MD, E. David Bravos, MD, Gillian R. Isaac, MD, PhD, Calvin A. Eng, MD, Christopher L. Wu, MD
 
Vol 1, No 4 (2005): September/October Comparison of transdermal fentanyl with codeine/paracetamol, in combination with radiotherapy, for the management of metastatic bone pain Abstract   PDF
Kyriaki Mystakidou, MD, PhD, Emmanuela Katsouda, MD, PhD, Vassilios Kouloulias, MD, PhD, John Kouvaris, MD, PhD, Marinos Tsiatas, MD, Lambros Vlahos, MD, PhD
 
Vol 12, No 6 (2016): November/December Complete Issue - November/December 2016 Details
Various Authors
 
Vol 9, No 1 (2013): January/February Composite measure to assess efficacy/gastrointestinal tolerability of tapentadol ER versus oxycodone CR for chronic pain: Pooled analysis of randomized studies Abstract
Sanjay Merchant, PhD, David Provenzano, MD, Samir Mody, PharmD, MBA, Kai Fai Ho, PhD, Mila Etropolski, MD
 
Vol 3, No 6 (2007): November/December Comprehensibility and readability of patient self-administered Opioid Assessment Screening Tools Abstract
Lorraine S. Wallace, PhD, Amy J. Keenum, PharmD, DO, Steven E. Roskos, MD
 
Vol 1, No 2 (2005): May/June Congratulations on the new journal Abstract   PDF
Mimi Mahon, PhD, FAAN
 
Vol 7, No 3 (2011): May/June Considerations for the upcoming FDA REMS proposal Abstract
John F. Peppin, DO, FACP, John J Coleman, PhD, Kenneth L. Kirsh, PhD
 
Vol 9, No 2 (2013): March/April Consumer attitudes about opioid addiction treatment: A focus group study in New York City Abstract
Nancy L. Sohler, PhD, MPH, Linda Weiss, PhD, James E. Egan, MPH, Carolina M. López, BS, Jamie Favaro, LMSW, Robert Cordero, MSW, Chinazo O. Cunningham, MD, MS
 
Vol 8, No 2 (2012): March/April Continuous hydromorphone for pain and sedation in mechanically ventilated infants and children Abstract
Pamela D. Reiter, PharmD, Jennifer Ng, PharmD, Emily L. Dobyns, MD
 
Vol 12, No 5 (2016): September/October Coprescribing naloxone for patients on chronic opioid therapy: Lessons learned from a patient-safety initiative in primary care training sites Abstract
William Delaney, MD, Jessica Huff, MPH, MS, Sandra Mini, MD, Aiswarya Thomas, MD, Ralph Tremaglio, MD
 
Vol 14, No 1 (2018): January/February Correlates of opiate misuse based on aberrant urine drug tests for patients on chronic opiate therapy in a safety-net, academic primary care clinic Abstract
Smita Bakhai, MD, MPH, FACP, Bright Thilagar, MD, Jessica L. Reynolds, PhD, Kenneth E. Leonard, PhD
 
Vol 6, No 2 (2010): March/April Correlation between myoclonus and the 3-glucuronide metabolites in patients treated with morphine or hydromorphone: A pilot study Abstract
Shawn McCann, MD, Tony L. Yaksh, PhD, Charles F. von Gunten, MD, PhD
 
Vol 13, No 3 (2017): May/June Cost of opioid-treated chronic low back pain: Findings from a pilot randomized controlled trial of mindfulness meditation-based intervention Abstract
Aleksandra E. Zgierska, MD, PhD, James Ircink, BBA, Cindy A. Burzinski, MS, Marlon P. Mundt, PhD
 
Vol 1, No 3 (2005): July/August Cotton candy Abstract   PDF
Robert E. Enck, MD, Editor-in-Chief
 
Vol 7, No 1 (2011): January/February Course of weight change during naltrexone versus methadone maintenance for opioid-dependent patients Abstract
David J. Mysels, MD, MBA, Suzanne K. Vosburg, PhD, Ileana Benga, MD, Frances R. Levin, MD, Maria A. Sullivan, MD, PhD
 
Vol 6, No 6 (2010): November/December Current concepts in the management of opioid-induced constipation Abstract
John Brandon Walters, MD, Marcos Montagnini, MD, FACP
 
Vol 7, No 3 (2011): May/June Current concepts in the management of opioid-induced constipation: A perfect review with an imperfect concept Abstract
Xiulu Ruan, MD, Marcos Montagnini, MD, FACP, Brandon JB Walters, MD
 
Vol 15, No 5 (2019): September/October Current practices in naloxone prescribing upon hospital discharge Abstract
Michelle Punzal, MD, Patricia Santos, MD, MBA, Xiaoshu Li, PhD, Douglas R. Oyler, PharmD, Alan M. Hall, MD
 
Vol 7, No 3 (2011): May/June Current status and evolving role of abuse-deterrent opioids in managing patients with chronic pain Abstract
Lynn Webster, MD, Barbara St. Marie, NP, Bill McCarberg, MD, Steven D. Passik, PhD, Sunil J. Panchal, MD, Eric Voth, MD
 
Vol 11, No 3 (2015): May/June Daily home opioid use in adults with sickle cell disease: The PiSCES project Abstract
Wally R. Smith, MD, Donna K. McClish, PhD, Bassam A. Dahman, PhD, James L. Levenson, MD, Imoigele P. Aisiku, MD, MSCR, Vanessa de A. Citero, MD, Viktor E. Bovbjerg, PhD, MPH, John D. Roberts, MD, Lynne T. Penberthy, MD, MPH, Susan D. Roseff, MD
 
Vol 14, No 3 (2018): May/June Daily opioid analgesic use reduces blood insulin levels Abstract
Christina Mueller, MS, Larry F. Chu, MD, Joanne C. Lin, PhD, Fernando Ovalle, MD, Jarred W. Younger, PhD
 
Vol 15, No 2 (2019): March/April Decline in primary care providers’ prescribing of Schedule II opioids following the implementation of federal and state guidelines Abstract
Lisa B. E. Shields, MD, Timothy A. Johnson, BS, James P. Murphy, MD, Douglas J. Lorenz, PhD, Alisha Bell, MSN, RN, CPN, Kenneth C. Wilson, MD, Steven T. Hester, MD, MBA, Joshua T. Honaker, MD, MBA, FAAP
 
Vol 11, No 4 (2015): July/August Decreased responsiveness to oxycodone: A case of a pharmacokinetic drug interaction? Abstract
Doreen Pon, PharmD, Joon Hwang, PharmD Candidate, Teresa Lo, PharmD Candidate, Carin Van Zyl, MD, FACEP
 
Vol 6, No 6 (2010): November/December Defining clinical issues around tolerance, hyperalgesia, and addiction: A quantitative and qualitative outcome study of long-term opioid dosing in a chronic pain practice Abstract
Jennifer P. Schneider, MD, PhD, Kenneth L. Kirsh, PhD
 
Vol 10, No 6 (2014): November/December Demographic characteristics and clinical predictors of patients discharged from university hospital-affiliated pain clinic due to breach in narcotic use contract Abstract
Shushovan Chakrabortty, MD, PhD, Deepak Gupta, MD, David Rustom, MD, Hussein Berry, Ajit Rai
 
Vol 7, No 4 (2011): July/August Depressive symptoms in community-dwelling older adults receiving opioid therapy for chronic pain Abstract
Robert Lavin, MD, Juyoung Park, PhD
 
Vol 13, No 3 (2017): May/June Detection of naltrexone and naltrexol in patients prescribed Embeda® Abstract
Robert West, MS, Maria Guevara, PharmD, Charles Mikel, PhD
 
Vol 2, No 6 (2006): November/December Determinants of variation in analgesic and opioid prescribing practice in an emergency department Abstract   PDF
Alan Heins, MD, Marianthe Grammas, BS, Janet Kaye Heins, RN, MSN, CRNP, Melissa W. Costello, MD, Kun Huang, MS, Satya Mishra, PhD
 
Vol 7, No 2 (2011): March/April Determination of medication cutoff values in a pain patient population Abstract
Amadeo Pesce, PhD, DABCC, Cameron West, PhD, Robert West, MS, Bridgit Crews, PhD, Charles Mikel, PhD, Murray Rosenthal, DO, FAPA, Perla Almazon, MT(ASCP), Sergey Latyshev, MS
 
Vol 15, No 4 (2019): July/August Developing opioid prescribing recommendations in the postoperative orthopedic setting Abstract
Daniel K. Haddad, PharmD, Orrin H. Sherman, MD
 
Vol 3, No 1 (2007): January/February Developmental pharmacokinetics of opioids in neonates Abstract   PDF
Karel Allegaert, MD, PhD, Sinno H. Simons, MD, PhD, Christine Vanhole, MD, PhD, Dick Tibboel, MD, PhD
 
Vol 8, No 3 (2012): May/June Dexmedetomidine and its increasing application in nonopioid detoxification Abstract
Shailendra Kapoor, MD
 
Vol 5, No 3 (2009): May/June Dexmedetomidine as a novel therapeutic for postoperative pain in a patient treated with buprenorphine Abstract
Chad M. Brummett, MD, Kavita A. Trivedi, DO, Anna V. Dubovoy, MD, Daniel W. Berland, MD
 
Vol 2, No 4 (2006): July/August Dexmedetomidine to treat opioid withdrawal in infants following prolonged sedation in the pediatric ICU Abstract   PDF
Joseph D. Tobias, MD
 
Vol 1, No 5 (2005): November/December Dextropropoxyphene and the cardiovascular system: About two cases of acute poisoning with cardiac conduction abnormalities Abstract   PDF
Frédérik Staikowsky, MD, PhD, Sébastien Candella, MD, Maurice Raphael, MD
 
Vol 14, No 5 (2018): September/October Dextropropoxyphene effects on QTc-interval prolongation: Frequency and characteristics in relation to plasma levels Abstract
Guillermo Alberto Keller, MD, PhD, Cecilia Villa Etchegoyen, MD, Nicolás Fernandez, PharmD, PhD, Nancy Mónica Olivera, PharmD, PhD, Patricia Noemí Quiroga, PharmD, PhD, Roberto Alejandro Diez, PhD, Guillermo Di Girolamo, MD, PhD
 
Vol 14, No 1 (2018): January/February Discharge prescribing of enteral opioids after initiation as a weaning strategy from continuous opioid infusions in the Intensive Care Unit Abstract
Bridgette Kram, PharmD, BCPS, BCCCP, Kylie M. Weigel, PharmD, BCPS, Michelle Kuhrt, PharmD, Daniel L. Gilstrap, MD
 
Vol 15, No 2 (2019): March/April Discussions between patients with chronic pain and their primary care provider about opioids and pain relief during routine clinic encounters Abstract
Mayra Massey, MMFT, Carissa Carissa van den Berk Clark, PhD, MSW, Jocelyn Fowler, MMFT, Jeffrey F. Scherrer, PhD
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Do abuse deterrent opioid formulations work? Abstract
Richard C. Dart, MD, PhD, Janetta L. Iwanicki, MD, Nabarun Dasgupta, PhD, Theodore J. Cicero, PhD, Sidney H. Schnoll, MD, PhD
 
Vol 4, No 1 (2008): January/February Do pain specialists meet the needs of the referring physician? A survey of primary care providers Abstract
Jane R. Wilkens, MD, Miles J. Belgrade, MD
 
Vol 8, No 2 (2012): March/April Do transdermal opioids affect the personal socioeconomic costs of healthcare access in an Australian rural pain population? A comparison with oral opioids Abstract
John S. Henshaw, MMed, FFPMANZCA, Judi Walker, PhD, Dom Geraghty, PhD
 
Vol 7, No 2 (2011): March/April Do transdermal opioids reduce healthcare use in an Australian rural pain population? A comparison with oral opioids Abstract
John S. Henshaw, MBBS, MMed, FANZCA, FFPMANZCA
 
Vol 13, No 6 (2017): November/December - Abuse Deterrent Opioids Special Issue Doctor driven problem or doctor driven solution? Abstract
Lynn R. Webster, MD, FACPM, FASAM
 
Vol 13, No 2 (2017): March/April Does caffeine improve respiratory rate during remifentanil target controlled infusion sedation? A case report in endoscopic sedation Abstract
Fabio Sbaraglia, MD, Mariella De Riso, MD, Maria Elena Riccioni, MD, Guido Costamagna, MD, Maria Sammartino, MD
 
Vol 14, No 2 (2018): March/April Does familiarity with CDC guidelines, continuing education, and provider characteristics influence adherence to chronic pain management practices and opioid prescribing? Abstract
Jean C. McCalmont, DNP, FNP, Kim D. Jones, PhD, FNP, FAAN, Robert M. Bennett, MD, FRCP, MACR, Ronald Friend, PhD
 
Vol 14, No 2 (2018): March/April Does nalbuphine have a niche in managing pain? Abstract
Mellar P. Davis, MD, FCCP, FAAHPM, Carlos Fernandez, MD, Sally Regel, CRNP, Mary Lynn McPherson, PharmD, MA, MDE, BCPS, CPE
 
Vol 11, No 3 (2015): May/June Does tapentadol affect sex hormone concentrations differently from morphine and oxycodone? An initial assessment and possible implications for opioid-induced androgen deficiency Abstract
Gary Eichenbaum, PhD, Karin Göhler, MD, Mila Etropolski, MD, Ilona Steigerwald, MD, PhD, Joseph Pergolizzi, MD, Myoung Kim, PhD, MA, Gary Vorsanger, PhD, MD
 
Vol 1, No 2 (2005): May/June Does the opioid-sparing effect of NSAIDs benefit the patient in the postoperative period? Abstract   PDF
Alexander Ng, MBChB, MD, FRCA, Justiaan Swanevelder, MBChB, MMed(Anaes), FCA(SA), FRCA
 
Vol 14, No 6 (2018): November/December Driving under the influence of opioids: What prescribers should know Abstract
Joseph V. Pergolizzi, Jr, MD, Robert Taylor, Jr, PhD, John Bisney, MA, Jo Ann LeQuang, BA, Robert B. Raffa, PhD, Fabianna Pergolizzi, JD, Daniel Colucci, Lisa Batastini, JD, BS Pharm
 
Vol 11, No 1 (2015): January/February Drug testing and adherence monitoring in pain management: Oral fluid testing Abstract
Christine Moore, PhD, DSc, DABCC
 
Vol 11, No 4 (2015): July/August Duration of intrathecal morphine effect in children with idiopathic scoliosis undergoing posterior spinal fusio Abstract
Bethany W. Ibach, PharmD, Carol Loeber, MSN, APRN-CNP, Mohanad Shukry, MD, Tracy M. Hagemann, PharmD, FCCP, FPPAG, Donald Harrison, PhD, FAPhA, Peter N. Johnson, PharmD, BCPS
 
Vol 2, No 2 (2006): March/April Early administration of oral morphine to orthopedic patients after surgery Abstract   PDF
Ruth Zaslansky, DSc, Elon Eisenberg, MD, Bezalel Peskin, MD, Elliot Sprecher, PhD, Daniel N. Reis, MD, Chaim Zinman, MD, Silviu Brill, MD
 
Vol 4, No 1 (2008): January/February Early analgesic effects of intravenous parecoxib and rectal diclofenac following laparoscopic sterilization: A double-blind, double-dummy randomized controlled trial Abstract
Alexander Ng, MD, FRCA, Ajay Swami, FFARCSI, Graham Smith, MD, FRCA, Joe Emembolu, FRCOG
 
Vol 10, No 1 (2014): January/February Early postoperative patient-controlled analgesia ratio predicts 24-hour morphine consumption and pain in children undergoing scoliosis surgery Abstract
Clyde T. Matava, MBCHB, Mark W. Crawford, MBBS, Carolyne Pehora, RN, Basem Naser, MD, Conor McDonnell, MBCHB
 
Vol 7, No 4 (2011): July/August Economic evaluation of OROS® hydromorphone for chronic pain: A Pan-European perspective Abstract
A. Brett Hauber, PhD, Jochen Fleischmann, PhD, Mickael Lothgren, PhD, Michele Wilson, MSPH, Annette Lam, MHEcon, Dominique Dubois, MD, Rainer Sabatowski, MD
 
Vol 4, No 4 (2008): July/August Edema caused by continuous epidural hydromorphone infusion: A case report and review of the literature Abstract
Xiulu Ruan, MD, Riaz Tadia, MD, Hainan Liu, MS, John Patrick Couch, MD, John Keun-Sang Lee, MD, PhD
 
Vol 10, No 4 (2014): July/August Editorial. The prescription opioid abuse epidemic in rural America: A look at how it begins Abstract
Stacey C. Sigmon, PhD, Amanda G. Kennedy, PharmD
 
Vol 10, No 5 (2014): September/October Educational gaps among healthcare providers: An institution needs assessment to improve pain management for postsurgical patients Abstract
Marlís González-Fernández, MD, PhD, Hanan Aboumatar, MD, MPH, Deena Conti, RN, MS, Amit M. Patel, MD, Michael A. Purvin, MD, Marie Hanna, MD
 
Vol 13, No 5 (2017): September/October Educational intervention for physicians to address the risk of opioid abuse Abstract
Margaret K. Pasquale, PhD, Richard L. Sheer, BA, Jack Mardekian, PhD, Elizabeth T. Masters, MS, MPH, Nick C. Patel, PharmD, PhD, Amy R. Hurwitch, PharmD, BCPS, Jennifer J. Weber, PharmD, MS, BCPS, CGP, BCACP, Anamaria Jorga, MD, Carl L. Roland, PharmD, MS
 
Vol 4, No 1 (2008): January/February Effect of buprenorphine on psychomotor functions in patients on buprenorphine maintenance Abstract
Ankush Singhal, MBBS, MD, MRCPsych, B.M. Tripathi, MBBS, MD, MRCPsych, Hem Raj Pal, MBBS, MD, Renuka Jena, PhD, Raka Jain, MSc, PhD, Cchem, FRSC
 
Vol 15, No 1 (2019): January/February Effect of different doses of remifentanil on stress response during laparoscopic cholecystectomy Abstract
Laura Levantesi, MD, Flaminio Sessa, MD, Elisabetta Congedo, MD, Francesco Di Nardo, MD, Marco Oggiano, MD, Gennaro Canistro, MD, Rossella Sicuranza, MD, Luca Nicosia, MD, Germano De Cosmo, PhD
 
Vol 11, No 2 (2015): March/April Effect of dosing interval on pharmacokinetics of fentanyl pectin nasal spray from a crossover study Abstract
Cuiping Chen, PhD, Shay Bujanover, MD, Anita Gupta, DO, PharmD
 
Vol 2, No 2 (2006): March/April Effect of drug and medical treatment on wide geographic variations in repeated emergency department use by HIV-infected drug users Abstract   PDF
Barbara J. Turner, MD, MSEd, Christine Laine, MD, MPH, Alan Kott, Walter W. Hauck, PhD
 
Vol 7, No 4 (2011): July/August Effect of fentanyl buccal tablet on pain-related anxiety: A 4-week open-label study among opioid-tolerant patients with chronic and breakthrough pain Abstract
Lynn R. Webster, MD, John Messina, PharmD, Fang Xie, PhD, Srinivas Nalamachu, MD
 
Vol 9, No 4 (2013): July/August Effect of intraoral and subcutaneous morphine on dyspnea at rest in terminal patients with primary lung cancer or lung metastases Abstract
Helle Gamborg, RN, Jette Riis, RN, Lona Christrup, MSc (Pharm), PhD, Torben Krantz, MD
 
Vol 4, No 2 (2008): March/April Effect of magnesium sulfate infusion on sevoflurane consumption, hemodynamics, and perioperative opioid consumption in lumbar disc surgery Abstract
Nihal Oguzhan, MD, Isil Gunday, MD, Alparslan Turan, MD
 
Vol 12, No 3 (2016): May/June Effect of preoperative intravenous oxycodone on sufentanil consumption after laparoscopic radical gastrectomy Abstract
Jinguo Wang, MD, PhD, Yaowen Fu, MD, PhD, Honglan Zhou, MD, PhD, Na Wang, MD, PhD
 
Vol 6, No 1 (2010): January/February Effect of preoperative rectal indomethacin on postoperative pain reduction after open appendectomy Abstract
Ali Jangjoo, MD, Mostafa Mehrabi Bahar, MD, Ehsan Soltani, MD
 
Vol 7, No 5 (2011): September/October Effect of prior treatment with ultra-low-dose morphine on opioid- and nerve injury-induced hyperalgesia in rats Abstract
Elzbieta P. Wala, PhD, Paul A. Sloan, MD, Joseph R. Holtman Jr, MD, PhD
 
Vol 12, No 3 (2016): May/June Effectiveness and tolerability of tapentadol sustained release in the Australian setting Abstract
Marc A. Russo, MBBS, DA(UK), FANZCA, FFPMANZCA, Danielle M. Santarelli, PhD
 
1 - 250 of 810 Items 1 2 3 4 > >>